# Dantrium

NDC: 42023-123
Generic name: dantrolene sodium
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20090420

FDA application: NDA018264

## Active ingredients

- DANTROLENE SODIUM: 20 mg/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-123"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-123
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4df35098-8702-46be-ac67-30cfdf1aa570